BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2276894)

  • 1. Pronounced increase of survival of patients with cardiomyopathy when treated with coenzyme Q10 and conventional therapy.
    Langsjoen PH; Folkers K; Lyson K; Muratsu K; Lyson T; Langsjoen P
    Int J Tissue React; 1990; 12(3):163-8. PubMed ID: 2276894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coenzyme Q10 in dilated cardiomyopathy.
    Manzoli U; Rossi E; Littarru GP; Frustaci A; Lippa S; Oradei A; Aureli V
    Int J Tissue React; 1990; 12(3):173-8. PubMed ID: 2276896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A six-year clinical study of therapy of cardiomyopathy with coenzyme Q10.
    Langsjoen PH; Langsjoen PH; Folkers K
    Int J Tissue React; 1990; 12(3):169-71. PubMed ID: 2276895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioenergetics in clinical medicine. VIII. Adminstration of coenzyme Q10 to patients with essential hypertension.
    Yamagami T; Shibata N; Folkers K
    Res Commun Chem Pathol Pharmacol; 1976 Aug; 14(4):721-7. PubMed ID: 785564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lack of effectiveness of coenzyme Q10 (ubiquinone) in long-term treatment of dilated cardiomyopathy].
    Permanetter B; Rössy W; Weingartner F; Bauer R; Seidl KF; Klein G
    Z Kardiol; 1989 Jun; 78(6):360-5. PubMed ID: 2667265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coenzyme Q10: clinical benefits with biochemical correlates suggesting a scientific breakthrough in the management of chronic heart failure.
    Mortensen SA; Vadhanavikit S; Muratsu K; Folkers K
    Int J Tissue React; 1990; 12(3):155-62. PubMed ID: 2276893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of coenzyme Q10 in patients with kidney diseases].
    Gazdíková K; Gvozdjáková A; Kucharská J; Spustová V; Braunová Z; Dzúrik R
    Cas Lek Cesk; 2001 May; 140(10):307-10. PubMed ID: 11411060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Coenzyme Q10: contractile dysfunction of the myocardial cell and metabolic therapy].
    Davini A; Cellerini F; Topi PL
    Minerva Cardioangiol; 1992 Nov; 40(11):449-53. PubMed ID: 1291925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term coenzyme Q10 therapy: a major advance in the management of resistant myocardial failure.
    Mortensen SA; Vadhanavikit S; Baandrup U; Folkers K
    Drugs Exp Clin Res; 1985; 11(8):581-93. PubMed ID: 3836876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioenergetics in clinical medicine. XVI. Reduction of hypertension in patients by therapy with coenzyme Q10.
    Folkers K; Drzewoski J; Richardson PC; Ellis J; Shizukuishi S; Baker L
    Res Commun Chem Pathol Pharmacol; 1981 Jan; 31(1):129-40. PubMed ID: 7255868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine.
    Hershey AD; Powers SW; Vockell AL; Lecates SL; Ellinor PL; Segers A; Burdine D; Manning P; Kabbouche MA
    Headache; 2007 Jan; 47(1):73-80. PubMed ID: 17355497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival of cancer patients on therapy with coenzyme Q10.
    Folkers K; Brown R; Judy WV; Morita M
    Biochem Biophys Res Commun; 1993 Apr; 192(1):241-5. PubMed ID: 8476426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial dysfunction in mitochondrial diabetes treated with Coenzyme Q10.
    Salles JE; Moisés VA; Almeida DR; Chacra AR; Moisés RS
    Diabetes Res Clin Pract; 2006 Apr; 72(1):100-3. PubMed ID: 16253379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Investigation of the preventive effect of CoQ10 against the side-effects of anthracycline antineoplastic agents].
    Tsubaki K; Horiuchi A; Kitani T; Taniguchi N; Masaoka T; Shibata H; Yonezawa T; Tsubakio T; Kawagoe H; Shinohara Y
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1420-7. PubMed ID: 6742867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective and safe therapy with coenzyme Q10 for cardiomyopathy.
    Langsjoen PH; Folkers K; Lyson K; Muratsu K; Lyson T; Langsjoen P
    Klin Wochenschr; 1988 Jul; 66(13):583-90. PubMed ID: 3062263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioenergetics in clinical medicine. Studies on coenzyme Q10 and essential hypertension.
    Yamagami T; Shibata N; Folkers K
    Res Commun Chem Pathol Pharmacol; 1975 Jun; 11(2):273-88. PubMed ID: 1153873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective treatment with coenzyme Q10 of patients with chronic myocardial disease.
    Langsjoen PH; Vadhanavikit S; Folkers K
    Drugs Exp Clin Res; 1985; 11(8):577-9. PubMed ID: 3836875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Only transient increase of serum CoQ subset 10 during long-term CoQ10 therapy in mitochondrial ophthalmoplegia.
    Hanisch F; Zierz S
    Eur J Med Res; 2003 Nov; 8(11):485-91. PubMed ID: 14644702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Beneficial long-term effects of diltiazem on the course of dilated cardiomyopathy].
    Figulla HR; von Rechenberg J; Wiegand V; Soballa R; Kreuzer H
    Z Kardiol; 1989; 78 Suppl 5():36-42. PubMed ID: 2517156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy with coenzyme Q10 of patients in heart failure who are eligible or ineligible for a transplant.
    Folkers K; Langsjoen P; Langsjoen PH
    Biochem Biophys Res Commun; 1992 Jan; 182(1):247-53. PubMed ID: 1731784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.